Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy

Background and Objectives: Atherosclerotic cardiovascular disease (CVD) remains a major cause of morbidity and mortality in persons with systemic lupus erythematosus (SLE, lupus). Atherosclerosis, which involves interplay between cholesterol metabolism and cellular inflammatory pathways, is primaril...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiss, Allison B., Arain, Hirra A., Kasselman, Lora J., Renna, Heather A., Zhen, Juan, Voloshyna, Iryna, DeLeon, Joshua, Carsons, Steven E., Petri, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780986/
https://www.ncbi.nlm.nih.gov/pubmed/31438615
http://dx.doi.org/10.3390/medicina55090514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780986/
https://www.ncbi.nlm.nih.gov/pubmed/31438615
http://dx.doi.org/10.3390/medicina55090514

Ejemplares similares